FN·Fabrinet

Fabrinet is a key player in advanced manufacturing, specializing in optical communications, industrial lasers, automotive, medical, and sensor industries by providing comprehensive services from process design to assembly and testing of complex components. Operating within the Technology sector, specifically the Electronic Components industry, the company enables high-speed data transmission and manufactures critical parts for various high-tech applications, serving global original equipment manufacturers. In its most recent reported quarters, Fabrinet demonstrated a positive trend in both earnings per share (EPS) and revenue. For Q3 2026, the company reported actual EPS of $3.72 against an estimate of $3.666, and actual revenue of $1.214 billion against an estimate of $1.215 billion. This follows a pattern of strong performance, with Q2 2026 showing actual EPS of null against an estimate of $3.3449 and actual revenue of null against an estimate of $1.109 billion, and Q3 2025 reporting actual EPS of $2.92 against an estimate of $2.81866 and actual revenue of $978.128 million. The company has shown a consistent ability to meet or exceed analyst expectations in recent periods, with EPS beats in Q4 2024 ($2.61 vs $2.49347), Q1 2025 ($2.52 vs $2.47276), Q2 2025 ($2.65 vs $2.62946), and Q3 2025 ($2.92 vs $2.81866), and Q3 2026 ($3.72 vs $3.666). Recent news highlights a record fiscal third-quarter revenue of $1.214 billion, a 39% year-over-year increase, driven by strong optical and non-optical segments, with record non-GAAP EPS of $3.72 exceeding guidance due to execution and favorable foreign exchange. However, component shortages impacted Datacom shipments, and revenue slightly missed expectations, leading to a post-market price decline. Investors will be watching for management's commentary on market dynamics, supply chain navigation, and the outlook for future results, particularly concerning the balance between strong earnings and revenue performance amidst potential constraints. Key will be the company's ability to manage supply chain issues and capitalize on demand in its core segments, as well as analyst sentiment shifts, such as a recent price target reduction to $744.00 by Argus Research, balanced against a Zacks Rank #2 (Buy) driven by upward EPS estimate revisions.